Microbiological Testing: Time is of the Essence

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-11-15-2016
Volume 2016 eBook
Issue 3
Pages: s33–s36

Pressures to accelerate current and next-gen therapies are challenging traditional microbiological testing models.

Effective microbiological testing during biopharmaceutical drug development and manufacturing is crucial for ensuring sterility, determining antimicrobial effectiveness, detecting microbial contamination or bioburden levels, analyzing endotoxins, and implementing environmental monitoring programs.

Growing pressures to increase productivity, flexibility, and cost-effectiveness and the unique properties of many next-generation therapies are challenging today’s microbiologists.

Download Pharmaceutical Technology’s 

2016 Quality Throughout the Supply Chain eBook

.

 

 

Articles in this issue
PTeBook1116_QMS_185.jpg
Extending QMS to Contract Partners
PTeBook1116_Agalloco_sterilization_185.jpg
Too Much by Half: Misapplication of the Half-Cycle Approach to Sterilization
PTeBook1116_HumanPerformance_BPOG_185.jpg
Investigation Effectiveness Drives Human Performance Excellence
PTeBook1116_Aging_Facilities_185.jpg
Is Global Regulatory Gridlock Slowing Modernization?
PTeBook1116_Instant_GMP_185.jpg
Paperless Batch Records for the Masses
PTeBook1116_Pharma_Report_Card_185.jpg
Could Greater Transparency Improve Pharmaceutical Quality and Compliance?
PTeBook1116_Capsugel_185.jpg
Ensuring Quality in Pharmaceutical Raw Materials
PTeBook1116_MicrobialTesting_Challener_185.jpg
Microbiological Testing: Time is of the Essence
Recent Videos
CPHI Milan 2024: Highlighting the Benefits of Integrated Services
Buy, Sell, Hold: Cell and Gene Therapy
Buy, Sell, Hold: Cell and Gene Therapy
Related Content
Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Three New European Facilities Established by BioPharmaSpec for R&D

Feliza Mirasol
November 21st 2024
Article

Located in German, Italy, and Lithuania, the new European facilities will specialize in drug discovery and R&D services.

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
June 25th 2024
Podcast

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

PTC Therapeutics Gains FDA Approval for AADC Deficiency Gene Therapy

Feliza Mirasol
November 19th 2024
Article

FDA's approval of eladocagene exuparvovec-tneq (Kebilidi) makes that product the first FDA-approved gene therapy for treating AADC deficiency.

Drug Solutions Podcast: All About Data: Looking at the EHDS in More Detail

Drug Solutions Podcast: All About Data: Looking at the EHDS in More Detail

Felicity Thomas
May 28th 2024
Podcast

In this episode, Alexander Natz from EUCOPE chats about the European Health Data Space.

Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

EMA’s CHMP Gives Positive Opinion for Use of Lecanemab in Early Alzheimer’s Disease

Felicity Thomas
November 16th 2024
Article

CHMP has granted Eisai Europe and Biogen a positive opinion for the use of their monoclonal antibody therapy in treating early Alzheimer’s disease.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

TrakCel’s OCELLOS Platform Selected to Support Treatment Management of Five Upcoming Cell Therapy Products

Feliza Mirasol
November 13th 2024
Article

Manufacturers of five autologous or matched allogenic cell therapy products have selected TrakCel's IT platform, OCELLOS, to orchestrate the administration of these therapies, which are approved or expected to be approved in 2024.